Market revenue in 2024 | USD 80.1 million |
Market revenue in 2030 | USD 141.9 million |
Growth rate | 10% (CAGR from 2025 to 2030) |
Largest segment | Sequence analysis platforms |
Fastest growing segment | Sequence Analysis Platforms |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 40.7% in 2024. Horizon Databook has segmented the Canada drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of trained scientists and laboratory associates that can handle wet laboratory and in-silico tools hand-in-hand in order to implement the process of drug development is supportive to contribute for the revenue generated from this region.
Additionally, there are several academic institutes that are involved in extensive drug designing projects which fuel the revenue generation from this region. Presence of regulatory authorities such as Health Canada and Canada.
Pharmaceutical Association supports post marketing surveillance activities thereby driving demand for the cloud-based services for clinical trial data management. Presences of organizations, responsible to promote the importance of medical information such as Canadian Institute.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada drug discovery informatics market , including forecasts for subscribers. This country databook contains high-level insights into Canada drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account